Preview

Systemic Hypertension

Advanced search

Effects of the b-blockers on the functional state of patients with ventricular arrhythmias

https://doi.org/10.26442/2075082X.2021.1.200246

Abstract

Sudden cardiac death and the heaviest arrhythmic events are connected to ventricular arrhythmias (VA). The issue of optimization of drug therapy for VA remains relevant. Given the possible multidirectional effects of antiarrhythmic drugs on the functional state, in order to determine the effectiveness of pharmacotherapy in patients with VA it is advisable to use a stepwise integrated approach. Aim. Compare the effects of bisoprolol, nebivolol and sotalol on the functional state of patients with VA. Materials and methods. 120 patients with VA of grade I-IV based on the В. Lown grading system, I-II groups based on J. Bigger grading system against the background of essential hypertension or its combination with coronary heart disease took part in the research, they were randomized into three groups for treatment with bisoprolol, nebivolol and sotalol. As part of combination therapy, patients were administered lisinopril, and if indicated, acetylsalicylic acid, atorvastatin. Initially and after 24 weeks of therapy the following was done: quantitative assessment of regulatory-adaptive status by cardio-respiratory synchronism test, treadmill test, six-minute walk test, subjective assessment of quality of life, all-day monitoring of blood pressure and electrocardiogram. Results. With comparable hypotensive and antiarrhythmic effects, therapy with nebivolol had a positive effect on the regulatory-adaptive status, had a better effect on exercise tolerance in comparison with bisoprolol and sotalol, more improved the quality of life, in comparison with bisoprolol and sotalol. Conclusion. In patients with VA against the background of essential hypertension or its combination with coronary heart disease as part of combination therapy the use of nebivolol may be preferable to bisoprolol or sotalol due to a more pronounced positive effect on the functional state.

About the Authors

I. Z. Shubitidze
Regional Clinical Hospital №2
Russian Federation


V. G. Tregubov
Regional Clinical Hospital №2; Kuban State Medical University
Russian Federation


References

1. Трешкур Т.В., Тулинцева Т.Э., Пармон Е.В., и др. Консервативная терапия неишемических желудочковых аритмий: опыт и перспектива. Кардиология и сердечно-сосудистая хирургия. 2013; 6 (5): 58-66.

2. Schleifer JW, Sorajja D, Shen WK. Advances in the pharmacologic treatment of ventricular arrhythmias. Expert Opin Pharmacother 2015; 16 (17): 2637-51. DOI: 10.1517/14656566.2015.1100170

3. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2015; 36 (41): 2793-867. DOI: 10.1714/2174.23496

4. Тарасов А.В. Вопросы безопасности антиаритмической терапии. Consilium Medicum. 2014; 16 (10): 44-9.

5. Герегей А.М., Ковалев А.С., Ветряков О.В., и др. Современные методы оценки функционального состояния организма и физической работоспособности военнослужащего при решении научно-исследовательских задач биомедицинской направленности. Вестн. Рос. военно-мед. академии. 2018; 2 (62): 202-8.

6. Pokrovskii VM. Alternative view of the mechanism of cardiac rhythmogenesis. Heart Lung Circ 2003; 12 (1): 18-24. DOI: 10.1046/j.1444-2892.2003.00192

7. Pokrovskii VM, Polischuk LV. Cardiorespiratory synchronism in estimation of regulatory and adaptive organism status. J Integr Neurosci 2016; 15 (1): 19-35. DOI: 10.1142/s0219635216500060

8. Покровский В.М., Пономарев В.В., Артюшков В.В., и др. Система для определения сердечно-дыхательного синхронизма у человека. Россия, 2009; патент № 86860.

9. Прокофьев АБ. Влияние антиаритмических лекарственных препаратов на качество жизни больных с нарушениями сердечного ритма. Лекарственные препараты и рациональная фармакотерапия. 2013; 1: 39-44.

10. Минушкина Л.О. Бисопролол: возможности в лечении артериальной гипертонии. Кардиология. 2012; 52 (6): 80-5.

11. Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, et al. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial. Eur J Heart Fail 2011; 13 (7): 765-72. DOI: 10.1093/eurjhf/hfr051

12. Toblli JE, DiGennaro F, Giani JF, et al. Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag 2012; 8: 151-60. DOI: 10.2147/vhrm.S20669

13. Шубик Ю.В., Чирейкин Л.В. Соталол в лечении аритмий. Вестн. аритмологии. 1998; 10: 80-3.

14. Трегубов В.Г., Макухин В.В., Фокина К.С., и др. Оценка регуляторно-адаптивных возможностей у пациентов с желудочковыми нарушениями ритма сердца. Кубанский научный мед. вестн. 2006; 9: 66-8.

15. Покровский ВМ. Сердечно-дыхательный синхронизм в оценке регуляторно-адаптивных возможностей организма. Краснодар: Кубань-Книга, 2010, с. 244.


Review

For citations:


Shubitidze I.Z., Tregubov V.G. Effects of the b-blockers on the functional state of patients with ventricular arrhythmias. Systemic Hypertension. 2021;18(1):19-24. (In Russ.) https://doi.org/10.26442/2075082X.2021.1.200246

Views: 163


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)